(Dallas, TX – July 7, 2009) Balfour Beatty Construction used a winning combination to achieve success on the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) Office Building: adopting a “do what is best for the project” mentality and maintaining a sense of urgency in the schedule. The result was substantial completion of construction three months early for the $93.7 million, 393,000-square-foot facility at the FDA campus in Silver Spring, MD. A formal dedication was held in May.
Throughout the project, Balfour Beatty provided the highest level of service to its clients, the General Services Administration (GSA) and the FDA. This included helping lead the effort to go beyond the LEED Certified sustainability requirements to meet the tougher, LEED Gold criteria.
“Balfour Beatty Construction is proud to have turned over this building to the GSA on-budget and ahead of schedule,” said David Laib, P.E., Balfour Beatty’s senior vice president who oversaw the project. “Through our team’s hard work and cooperative approach, we delivered not just a building but a construction experience that the GSA and FDA can be proud of for years to come.”
The six-story, concrete-framed project is built to progressive collapse specifications. Its exterior is made of brick, cast stone and curtain wall. Steel pedestrian bridges on the second and third floors link the building to adjacent laboratory facilities. Besides office areas, the interior features a 150-person conference center and high-density storage space. The building’s centerpiece is a grand, six-story atrium that runs the length of the building, with clerestory windows above providing abundant daylight.
Balfour Beatty provided general construction services on the project. Other members of the CDRH project team included Tishman Construction Corp. of Maryland, construction manager; KlingStubbins in association with RTKL Associates, architecture and engineering designers; Dynalectric Company, electrical subcontractor; Pierce Associates, mechanical subcontractor; Miller & Long Company, concrete subcontractor; Tidewater Glazing, glass and glazing subcontractor; and Manganaro Midatlantic, drywall subcontractor.
The CDRH Office Building is the third project Balfour Beatty has completed since 2004 at the FDA’s Silver Spring campus. Balfour Beatty also built the $89.2 million, 573,261-square-foot Center for Drug Evaluation and Research Office Building, and the $42 million, 123,000-square-foot Central Shared Use Building, which houses administrative functions.
About Balfour Beatty Construction
Balfour Beatty Construction has been a leader in the U.S. commercial construction industry for 76 years, providing general contracting, at-risk construction management, design-build, preconstruction, public/private and turnkey services for clients nationwide. The company employs 1,650 professionals and is part of London-based Balfour Beatty plc, a leading international engineering, construction, and investment business exceeding $16 billion in annual revenues. For more information, visit www.balfourbeattyus.com.
Balfour Beatty Construction
Vice President, Corporate Communications